MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-KR-03-0175637
Om Pharmaceuticals Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹83.53 Cr
▲ 6% YoY
Net profit · FY 2025
₹7.05 Cr
Net margin 8.4%
EBITDA · FY 2025
₹11.6 Cr
EBITDA margin 13.9%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹9.2 Lakh
Issued & subscribed
Open charges
₹40 Lakh
Satisfied ₹8.95 Cr
Company age
32 yrs
Est. 1994
Directors on board
4
As per MCA filings
About Om Pharmaceuticals Limited
Data last updated:
Om Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 08 November 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1994PLC082689. Its GSTIN is 29AAACO0976E1ZF (Karnataka).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹9.2 Lakh. It is led by directors including Chetan Doshi Mansukhlal and Vivek Gul Asrani.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 202 Vishwa Nanak Apartments Gurunanak Wadi Chakala Andheri (East), Mumbai, Maharashtra, India – 400099.
As per the financials filed for FY 2025, the company reported a revenue of ₹83.53 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹7.05 Cr (net margin 8.4%) and EBITDA of ₹11.6 Cr (EBITDA margin 13.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 12% over five years.
The company is associated with 2 brands: Om Pharmaceutical Industries and Shree Dhootapapeshwar. As per MCA filings, the company has open charges of ₹40 Lakh and satisfied charges of ₹8.95 Cr on record. Court records list 11 cases involving the company, including 4 filed by the company and 7 filed against it; 4 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in April 2022. Its 6 peer companies in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Prachi Pharmaceuticals Private Limited with revenue of ₹85.43 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 40 overdue payments to 15 micro and small suppliers.
Om Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0175637). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sdlindia.com.
Company details
CIN U24230MH1994PLC082689
Registration Number 082689
Incorporation Date 08 November 1994
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KR-03-0175637
Key People
Chetan Doshi Mansukhlal Director Vivek Gul Asrani Director Vishal Narindernath Mehra Director Recognitions & Rankings of Om Pharmaceuticals
Contact details
Om Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its website is sdlindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address202 Vishwa Nanak Apartments Gurunanak Wadi Chakala Andheri (East), Mumbai, Maharashtra, India – 400099
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Om Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Om Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Om Pharmaceuticals operates two associated brands: Om Pharmaceutical Industries and Shree Dhootapapeshwar. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies active pharmaceutical ingredients and intermediates with FDA-approved facilities. | ompharmaceutical.com | |
| Ayurvedic medicines | sdlindia.com |
Business activity
The main business activity of Om Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Om Pharmaceuticals Limited, buy the company report.
Financials of Om Pharmaceuticals Limited
FY 2025 filings availableOm Pharmaceuticals Limited reported revenue of ₹83.53 Cr (up 6% YoY) for FY 2025.
Revenue · FY 2025
₹83.53 Cr ▲ 6%
Net profit · FY 2025
₹7.05 Cr margin 8.4%
EBITDA · FY 2025
₹11.6 Cr margin 13.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 9%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 9%
5 years · compounded
▲ 15%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 6% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.6 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.05 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.9% | ||||
| Net Profit Margin | 8.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Om Pharmaceuticals Limited, buy the company report.
Board of directors of Om Pharmaceuticals Limited
Om Pharmaceuticals has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chetan Doshi Mansukhlal Also directs: U.D. Industries Private Limited | Director | 27 Dec 2019 | 6 Years 9 Months | Current |
| Vivek Gul Asrani Also directs: GRP Limited, Cartrade Tech Limited, Indo-Italian Furniture Company Private Limited and 3 more | Director | 01 Apr 2005 | 21 Years 6 Months | Current |
| Vishal Narindernath Mehra | Director | 20 Jul 2012 | 14 Years 3 Months | Current |
| Pravin Gangadhar Sonawane | Director | 09 Sep 2024 | 2 Years 1 Months | Current |
Peer comparison
Om Pharmaceuticals Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prachi Pharmaceuticals Private Limited | ₹85.43 Cr (FY 2024) | -3.0% | Mumbai, Maharashtra, India | |||
| Hema Pharmaceuticals Pvt Ltd | ₹85.23 Cr (FY 2025) | 17.0% | Ankleshwar, Gujarat, India | |||
| Macmillon Pharmaceuticals Private Limited | ₹83.91 Cr (FY 2024) | 50.0% | Punjab, India | |||
| Om Pharmaceuticals Limitedthis company | ₹83.53 Cr (FY 2025) | ₹7.05 Cr | 8.4% | 6.0% | Mumbai, Maharashtra, India | |
| Nagarjuna Herbal Concentrates Ltd | ₹83.43 Cr (FY 2025) | 1.0% | Thodupuzha, Kerala, India | |||
| Abhilash Chemicals and Pharmaceuticals Private Limited | ₹82.45 Cr (FY 2025) | -16.0% | Madurai, Tamil Nadu, India | |||
| Maxheal Pharmaceuticals (India) Limited | ₹82.41 Cr (FY 2024) | 10.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Om Pharmaceuticals Limited, buy the company report.
Auditor
Om Pharmaceuticals Limited is audited by KALYANIWALLA & MISTRY LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KALYANIWALLA & MISTRY LLP | FY 2023 | 104607W/W100166 |
Shareholding
The shareholding of Om Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Om Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹40 Lakh
Satisfied charges
₹8.95 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Sep 2024 | 100975176 | Others | ₹40 Lakh | Open | |
| 10 Oct 2013 | 10456602 | Bank of Maharashtra | ₹85 Lakh | Satisfied | |
| 03 Nov 2011 | 10317475 | Bank of Maharashtra | ₹1.1 Cr | Satisfied | |
| 08 Jul 2010 | 10233504 | Bank of Maharashtra | ₹1.35 Cr | Satisfied | |
| 03 Apr 2007 | 10050777 | Others | ₹3.2 Cr | Satisfied |
To see the full charge records of Om Pharmaceuticals Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Om Pharmaceuticals Limited has 1 deal on record (1 secondary share transfer); the latest was in April 2022.
Total deals
1
Secondary share transfer
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Om Pharmaceuticals Limited has 11 court cases on record: 4 filed by Om Pharmaceuticals, 7 filed against it. 4 cases are pending and 7 are disposed.
Total cases
11
Filed by the company
4
Filed against the company
7
Pending
4
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 4 | 1 |
| District courts | 3 | 2 | 2 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Krishna, Andhra Pradesh | Criminal case | Filed against the company by The State Rep by Andhra Pradesh Rep by the Drug Inspector | Pending |
| Supreme Court | Court case | Filed against the company by Union of India | Pending |
| District court, Khammam, Telangana | Criminal complaint | Filed against the company by an individual | Pending |
| High Court | Writ petition | Filed by the company against The State of Karnataka and 3 others | Pending |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against The Deputy Commissioner of Income Tax Circle 2( and 4 others | Disposed |
To see the full case history of Om Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Om Pharmaceuticals Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 40 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 15)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| SNS Print N Pack | |||
| an individual supplier | |||
| Ideal Cures Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Om Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Om Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAACO0976E1ZF | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Om Pharmaceuticals Limited, buy the company report.
Recent activity
Om Pharmaceuticals Limited has 9 board changes on record since 2005: 4 appointments and 5 cessations. The latest: Pravin Gangadhar Sonawane ceased to be Additional Director on 15 Sep 2024.
AGM
Om Pharmaceuticals Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Om Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Pravin Gangadhar Sonawane ceased to be Additional Director.
Appointed
Pravin Gangadhar Sonawane was appointed as Director.
Charges
A charge with Others amounted to Rs. 40.00 Lakh with Charge ID 100975176 was registered on 06 Sep 2024.
Charges
A charge registered on 03 Apr 2007 via Charge ID 10050777 with Others was fully satisfied on 24 Mar 2024.
Ceased
Chetan Doshi Mansukhlal ceased to be Director Appointed In Casual Vacancy.
Charges
A charge registered on 10 Oct 2013 via Charge ID 10456602 with Bank Of Maharashtra was fully satisfied on 11 Aug 2020.
Appointed
Chetan Doshi Mansukhlal was appointed as Director.
Ceased
Swaminathan Suryanarayanan ceased to be Director.
Charges
A charge with Others of Rs. 320.00 Lakh registered on 03 Apr 2007 with Charge ID 10050777 was modified on 22 Sep 2017.
Charges
A charge registered on 03 Nov 2011 via Charge ID 10317475 with Bank Of Maharashtra was fully satisfied on 13 Sep 2017.
16 earlier events are in the company report.
Frequently asked questions
Om Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 08 November 1994 (32+ years old) and is registered under CIN U24230MH1994PLC082689.
Om Pharmaceuticals has 4 current directors:
- Chetan Doshi Mansukhlal - Director
- Vivek Gul Asrani - Director
- Vishal Narindernath Mehra - Director
- Pravin Gangadhar Sonawane - Director
The latest financial statements of Om Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Om Pharmaceuticals is 29AAACO0976E1ZF, registered in Karnataka.
The CIN (Corporate Identification Number) of Om Pharmaceuticals is U24230MH1994PLC082689. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Om Pharmaceuticals has 11 court cases on record: 4 filed by the company and 7 filed against it. 4 are pending. Most are in the high courts.
Om Pharmaceuticals was incorporated on 08 November 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.
Om Pharmaceuticals has 1 deal on record (1 secondary share transfer); the latest was in April 2022.
The peers of Om Pharmaceuticals by revenue are Prachi Pharmaceuticals Private Limited, Hema Pharmaceuticals Pvt Ltd, Macmillon Pharmaceuticals Private Limited, Nagarjuna Herbal Concentrates Ltd, Abhilash Chemicals and Pharmaceuticals Private Limited and 1 more, all in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pravin Gangadhar Sonawane ceased to be Additional Director on 15 Sep 2024. Pravin Gangadhar Sonawane was appointed as Director on 09 Sep 2024. Chetan Doshi Mansukhlal ceased to be Director Appointed In Casual Vacancy on 30 Sep 2022. Om Pharmaceuticals has 9 board changes on record in total.
Yes, Om Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-KR-03-0175637).
Om Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 40 overdue payments to 15 micro and small suppliers. The latest return was filed on 31 May 2019.